Related Experiment Video
Updated: Jun 4, 2025

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
Published on: May 20, 2016
Optimizing topical nasal steroid application in adenoid hypertrophy: A computational fluid dynamics (CFD) analysis.
Bigyan Raj Gyawali1, Ashutosh Kashyap2, Sanju Thapa3
1Department of ENT-HNS, Maharajgunj Medical Campus, T.U. Teaching Hospital, Kathmandu, Nepal.
Optimizing intranasal steroid delivery for children with adenoid hypertrophy is crucial. A 30° nozzle angle maximizes medication deposition in the adenoid region, enhancing treatment effectiveness.
Area of Science:
- Otolaryngology
- Pediatric Respiratory Medicine
- Pharmacology
Background:
- Intranasal steroids are a key treatment for pediatric adenoid hypertrophy.
- Optimal application techniques for maximizing drug delivery to adenoids are not well-established.
- Existing guidelines are generalized from other nasal conditions.
Purpose of the Study:
- To determine the optimal nasal spray technique for maximizing drug deposition in the adenoid region.
- To address the research gap in understanding technique variations for adenoid hypertrophy treatment.
Main Methods:
- Computational Fluid Dynamics (CFD) analysis with discrete phase modeling.
- Simulation of nasal spray delivery within the nasal cavity and to the adenoid region.
- Validation of simulation findings using a 3D CT-based model.
Main Results:
- Maximum spray deposition in the adenoid region was achieved with an injection angle of 30°.
- Optimal concentration for deposition was observed at 14 kg/m³.
Conclusions:
- A 30° nozzle inclination relative to the nasal floor ensures maximal drug delivery to adenoids.
- This optimized technique is likely to improve the efficacy of intranasal steroid treatment for adenoid hypertrophy.
- Findings provide evidence-based guidance for nasal steroid application in pediatric adenoid hypertrophy.
Related Concept Videos
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

